Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FNR7R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,053
Award facts
- Contract value 100% obligated
- $26,053.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,053.32 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 15, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhaler medication in a 60-dose configuration. This is a non-set-aside, competitively awarded contract with an ultimate completion date of January 16, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., a prominent healthcare solutions provider registered in the System for Award Management.
This delivery order represents a task order executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. Trelegy Ellipta is a combination respiratory medication commonly used in the treatment of chronic obstructive pulmonary disease, demonstrating the company's role in delivering essential therapeutics to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FNR7R?
SPE2DR26FNR7R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FNR7R worth?
The government has obligated $26,053 on SPE2DR26FNR7R.
Is contract SPE2DR26FNR7R an order under another contract?
Yes. SPE2DR26FNR7R is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR7R competed?
The extent of competition for SPE2DR26FNR7R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award